News | July 12, 2025
Indegene launches NEXT Medical Writing Automation
To streamline complex medical writing workflows with GenAI
To streamline complex medical writing workflows with GenAI
Friesland Campina Professional’s innovative Kievit portfolio features fat powders, creamers, foamers, whipping agents, cake emulsifiers
Apollo AyurVAID’s product line features clinically proven formulations certified safe by NABL-accredited laboratories for heavy metals, aflatoxins, microbial content
These medicines are essential in preventing RhD immunisation during pregnancy
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
Approval based on NIAGARA Phase III trial results which showed a 32% reduction in the risk of recurrence and a 25% reduction in the risk of death for the Imfinzi regimen vs. neoadjuvant chemotherapy alone
atai and Beckley Psytech plan to meet with the U.S. Food and Drug Administration (FDA) and other regulatory agencies to finalize the Phase 3 trial design.
Enhance strategies to drive sustainability, global Reach and digital transformation for a trillion-dollar future
The approval in China is supported by a robust local clinical development program confirming the drug’s safety, tolerability, and efficacy profile
The approval is based on a comprehensive package of analytical, nonclinical, and clinical data
Subscribe To Our Newsletter & Stay Updated
